316 related articles for article (PubMed ID: 16759055)
1. In vitro evaluation of the anti-HIV activity and metabolic interactions of tenofovir and emtricitabine.
Borroto-Esoda K; Vela JE; Myrick F; Ray AS; Miller MD
Antivir Ther; 2006; 11(3):377-84. PubMed ID: 16759055
[TBL] [Abstract][Full Text] [Related]
2. Tenofovir disoproxil fumarate-emtricitabine coformulation for once-daily dual NRTI backbone.
Muñoz de Benito RM; Arribas López JR
Expert Rev Anti Infect Ther; 2006 Aug; 4(4):523-35. PubMed ID: 17009933
[TBL] [Abstract][Full Text] [Related]
3. Lack of a metabolic and antiviral drug interaction between tenofovir, abacavir and lamivudine.
Ray AS; Myrick F; Vela JE; Olson LY; Eisenberg EJ; Borroto-Esodo K; Miller MD; Fridland A
Antivir Ther; 2005; 10(3):451-7. PubMed ID: 15918336
[TBL] [Abstract][Full Text] [Related]
4. Dead-end complexes contribute to the synergistic inhibition of HIV-1 RT by the combination of rilpivirine, emtricitabine, and tenofovir.
Kulkarni R; Feng JY; Miller MD; White KL
Antiviral Res; 2014 Jan; 101():131-5. PubMed ID: 24291780
[TBL] [Abstract][Full Text] [Related]
5. The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study.
Feng JY; Ly JK; Myrick F; Goodman D; White KL; Svarovskaia ES; Borroto-Esoda K; Miller MD
Retrovirology; 2009 May; 6():44. PubMed ID: 19439089
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors.
Venhoff N; Setzer B; Melkaoui K; Walker UA
Antivir Ther; 2007; 12(7):1075-85. PubMed ID: 18018766
[TBL] [Abstract][Full Text] [Related]
7. Anti-hepatitis B virus activity in vitro of combinations of tenofovir with nucleoside/nucleotide analogues.
Zhu Y; Curtis M; Qi X; Miller MD; Borroto-Esoda K
Antivir Chem Chemother; 2009; 19(4):165-76. PubMed ID: 19374144
[TBL] [Abstract][Full Text] [Related]
8. On-line coupling of anion exchange and ion-pair chromatography for measurement of intracellular triphosphate metabolites of reverse transcriptase inhibitors.
Kuklenyik Z; Martin A; Pau CP; Holder A; Youngpairoj AS; Zheng Q; Cong ME; Garcia-Lerma JG; Heneine W; Pirkle JL; Barr JR
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Nov; 877(29):3659-66. PubMed ID: 19783232
[TBL] [Abstract][Full Text] [Related]
9. Antiretroviral efficacy and virological profile of a zidovudine/lamivudine/tenofovir disoproxil fumarate combination therapy in antiretroviral-naive patients.
Masquelier B; Neau D; Boucher S; Lavignolle-Aurillac V; Schrive MH; Recordon-Pinson P; Ragnaud JM; Fleury H
Antivir Ther; 2006; 11(6):827-30. PubMed ID: 17310827
[TBL] [Abstract][Full Text] [Related]
10. Virologic and enzymatic studies revealing the mechanism of K65R- and Q151M-associated HIV-1 drug resistance towards emtricitabine and lamivudine.
Feng JY; Myrick FT; Margot NA; Mulamba GB; Rimsky L; Borroto-Esoda K; Selmi B; Canard B
Nucleosides Nucleotides Nucleic Acids; 2006; 25(1):89-107. PubMed ID: 16440988
[TBL] [Abstract][Full Text] [Related]
11. In vitro interactions between apricitabine and other deoxycytidine analogues.
Bethell R; De Muys J; Lippens J; Richard A; Hamelin B; Ren C; Collins P
Antimicrob Agents Chemother; 2007 Aug; 51(8):2948-53. PubMed ID: 17517847
[TBL] [Abstract][Full Text] [Related]
12. Emtricitabine/tenofovir in the treatment of HIV infection: current PK/PD evaluation.
Uglietti A; Zanaboni D; Gnarini M; Maserati R
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1305-14. PubMed ID: 22943210
[TBL] [Abstract][Full Text] [Related]
13. In vitro analysis of synergism and antagonism of different nucleoside/nucleotide analogue combinations on the inhibition of human immunodeficiency virus type 1 replication.
Perez-Olmeda M; Garcia-Perez J; Mateos E; Spijkers S; Ayerbe MC; Carcas A; Alcami J
J Med Virol; 2009 Feb; 81(2):211-6. PubMed ID: 19107982
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of the acyclic nucleoside phosphonate tenofovir toward human T-cell leukemia/lymphotropic virus type 1 infection of human peripheral blood mononuclear cells in vitro.
Balestrieri E; Sciortino MT; Mastino A; Macchi B
Antiviral Res; 2005 Dec; 68(3):154-62. PubMed ID: 16271772
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients.
Bonora S; Gonzalez de Requena D; D'Avolio A; Calcagno A; Tettoni M; Siccardi M; Baietto L; Simiele M; Trentini L; Di Perri G
Antivir Ther; 2011; 16(4):499-504. PubMed ID: 21685537
[TBL] [Abstract][Full Text] [Related]
16. The antiretroviral potency of emtricitabine is approximately 3-fold higher compared to lamivudine in dual human immunodeficiency virus type 1 infection/competition experiments in vitro.
Drogan D; Rauch P; Hoffmann D; Walter H; Metzner KJ
Antiviral Res; 2010 Jun; 86(3):312-5. PubMed ID: 20302887
[TBL] [Abstract][Full Text] [Related]
17. Concomitant administration of BILR 355/r with emtricitabine/tenofovir disoproxil fumarate increases exposure to emtricitabine and tenofovir: a randomized, open-label, prospective study.
Huang F; Scholl P; Huang DB; MacGregor TR; Taub ME; Vinisko R; Castles MA; Robinson P
Basic Clin Pharmacol Toxicol; 2011 Mar; 108(3):163-70. PubMed ID: 20977679
[TBL] [Abstract][Full Text] [Related]
18. Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir.
Marchand B; White KL; Ly JK; Margot NA; Wang R; McDermott M; Miller MD; Götte M
Antimicrob Agents Chemother; 2007 Aug; 51(8):2911-9. PubMed ID: 17517852
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of HIV-1 replication in macrophages by a heterodinucleotide of lamivudine and tenofovir.
Rossi L; Franchetti P; Pierigé F; Cappellacci L; Serafini S; Balestra E; Perno CF; Grifantini M; Caliò R; Magnani M
J Antimicrob Chemother; 2007 Apr; 59(4):666-75. PubMed ID: 17327293
[TBL] [Abstract][Full Text] [Related]
20. Synergy against drug-resistant HIV-1 with the microbicide antiretrovirals, dapivirine and tenofovir, in combination.
Schader SM; Colby-Germinario SP; Schachter JR; Xu H; Wainberg MA
AIDS; 2011 Aug; 25(13):1585-94. PubMed ID: 21633286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
